Brazil’s National Health Surveillance Agency (Anvisa) has opened a sectoral consultation on its proposed draft Regulatory Agenda for 2013-2014. The Preliminarily Proposed Themes were develope...read more
A notice clarifying the rights of individuals who participate as clinical research subjects in Brazil was published by the country’s National Health Surveillance Agency (Anvisa) on January 2....read more
As of January 1, 2013, a national system will monitor the advertising of products regulated by the State FDA that are run on national and municipal radio stations, TV, and newspapers. The nat...read more
The Patients for Patient Safety in Health Care Project launched by Brazil’s national regulatory agency, Anvisa, includes a brochure that guides the patient to ask questions that are...read more
China’s State Food and Drug Administration (SFDA) issued a notice to the provinces and autonomous regions on December 10 announcing the classification of 17 medical devices based on expert ad...read more
The Eighteen Party Congress stressed focusing on promoting the safety of the country’s drug supply, a comprehensive reform of the regulatory system to improve food and drug safety supervision...read more
On December 15, Anvisa launched the strategic alignment of its regulatory agenda for the next four years. The new model announced by the agency brings some changes, especially in the improvement of...read more
At the 18th National People's Congress of the Communist Party of China, the Party called for the comprehensive reform of the food and drug regulatory system in order to respond to the concerns of t...read more
Brazil’s national regulatory agency, Anvisa, underscored its commitment to global cooperation by signing a series of bilateral agreements on regulatory cooperation during the 7th Summit of He...read more
China’s State FDA transmitted a notice of the 21 regulatory reforms mandated by the State Council to the provinces and autonomous regions on November 15. The reforms include the decentr...read more